Shares of Acasti Pharma Inc. (CVE:ACST – Get Free Report) rose 1.8% on Thursday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares traded hands during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Trading Up 1.8 %
The firm has a 50-day moving average of C$0.58 and a two-hundred day moving average of C$0.58. The firm has a market capitalization of C$25.87 million, a P/E ratio of -1.07 and a beta of 1.22. The company has a current ratio of 9.74, a quick ratio of 9.41 and a debt-to-equity ratio of 0.52.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Featured Stories
- Five stocks we like better than Acasti Pharma
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- 3 Small Caps With Big Return Potential
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- How to Choose Top Rated Stocks
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
